Literature DB >> 1650679

Mediastinal nodal involvement and the prognosis of non-small cell lung cancer.

Y Watanabe1, Y Hayashi, J Shimizu, M Oda, T Iwa.   

Abstract

We evaluated the effect of mediastinal lymph node metastasis on survival in 233 non-small cell lung cancer patients (N2 disease in 199 patients and N3 disease in 34 patients). Of the 199 patients with N2 disease, 144 underwent curative resection. The five-year survival rate of these 144 patients was 20.3 percent, which was significantly better than that of either the noncuratively resected N2 group or the N3 group. Nodal metastases in the curatively resected patients involved superior and inferior mediastinum irrespective of the location of the primary tumor. Patients with right-sided N2 lesions and metastases to the superior mediastinum had a worse survival than those with metastases to the inferior mediastinum. In contrast, patients with left-sided N2 lesions metastasizing to the inferior mediastinum had a significantly worse survival than those with lesions metastasizing to the superior mediastinum. Patients with single-level metastases had a significantly better survival rate than those with multilevel metastases. Subcarinal nodal involvement had an unfavorable effect in case of single-level metastasis, but did not affect the survival in cases of multilevel metastases. Our present study indicated that the survival of patients with N2 disease was affected by the operative radicality, by the number of levels of metastases, and also by the location of the nodal involvement. It seems appropriate that extensive mediastinal dissection should be performed irrespective of the location of the primary tumor.

Entities:  

Mesh:

Year:  1991        PMID: 1650679     DOI: 10.1378/chest.100.2.422

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Usefulness of dual-energy CT scanning at 80 kVp for identifying hilar and mediastinal structures: evaluation of contrast enhancement of the pulmonary vessels and lymph nodes.

Authors:  Ayano Imafuji; Masaki Hara; Shigeru Sasaki; Toshinao Arakawa; Yoshiyuki Ozawa; Yuta Shibamoto
Journal:  Jpn J Radiol       Date:  2011-12-03       Impact factor: 2.374

2.  Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients.

Authors:  Shinichiro Miyoshi; Kazuhiko Shien; Shinichi Toyooka; Kentaroh Miyoshi; Hiromasa Yamamoto; Seiichiro Sugimoto; Junichi Soh; Makio Hayama; Masaomi Yamane; Takahiro Oto
Journal:  Surg Today       Date:  2013-10-31       Impact factor: 2.549

3.  Survival after resection for primary lung cancer: a population based study of 3211 resected patients.

Authors:  T-E Strand; H Rostad; B Møller; J Norstein
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

Review 4.  Mind-mapping for lung cancer: towards a personalized therapeutics approach.

Authors:  N Mollberg; M Surati; C Demchuk; R Fathi; A K Salama; A N Husain; T Hensing; R Salgia
Journal:  Adv Ther       Date:  2011-02-09       Impact factor: 3.845

Review 5.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

Review 6.  Lymph node dissection for lung cancer: past, present, and future.

Authors:  Shun-ichi Watanabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-15

7.  'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)

Authors:  M F Jefferson; N Pendleton; E B Faragher; G R Dixon; M W Myskow; M A Horan
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

8.  Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.

Authors:  Masaya Tamura; Isao Matsumoto; Daisuke Saito; Shuhei Yoshida; Munehisa Takata; Hirofumi Takemura
Journal:  World J Surg Oncol       Date:  2016-11-25       Impact factor: 2.754

9.  The relationship between cardiac radiation dose and mediastinal lymph node involvement in stage III non-small cell lung cancer patients.

Authors:  Laura K McNew; Stephen R Bowen; Olga Gopan; Matthew J Nyflot; Shilpen A Patel; Jing Zeng; Ramesh Rengan
Journal:  Adv Radiat Oncol       Date:  2017-02-01

10.  The prognostic significance of multiple station N2 in patients with surgically resected stage IIIA N2 non-small cell lung cancer.

Authors:  Jin Gu Lee; Chang Young Lee; In Kyu Park; Dae Joon Kim; Sang Ho Cho; Kil Dong Kim; Kyung Young Chung
Journal:  J Korean Med Sci       Date:  2008-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.